Delayed fingolimod-associated asystole. [Mult Scler. 2011] – PubMed – NCBI

Posted on January 16, 2013 by Maurice Preter MD

Mult Scler. 2011 Nov;17(11):1387-9. doi: 10.1177/1352458511410344. Epub 2011 Jun 7.

Delayed fingolimod-associated asystole.

Espinosa PS, Berger JR.

Source

North Oaks Neurology, Hammond, LA, USA. ps.espinosa@gmail.com

Abstract

Oral fingolimod (Gilenya) is a sphingosine-1-phosphate-receptor modulator that prevents the egress of lymphocytes from lymph nodes. Fingolimod reduces relapses and delays disability progression in patients with relapsing forms of multiple sclerosis (MS). We report a patient with MS who developed asystole and sustained bradycardia 21 hours after the first dose of fingolimod.

PMID:

21652609

[PubMed – indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

LinkOut – more resources

via Delayed fingolimod-associated asystole. [Mult Scler. 2011] – PubMed – NCBI.

Maurice Preter, MD

About Maurice Preter MD

Maurice Preter, MD is a European and U.S. educated psychiatrist, psychotherapist, psychopharmacologist, neurologist, and medical-legal expert in private practice in Manhattan. He is also the principal of Fifth Avenue Concierge Medicine, PLLC, a medical concierge service and health advisory for select individuals and families.
This entry was posted in Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, keto, new treatments, Psychiatry/Neurology and tagged , , . Bookmark the permalink.